Description: Years of costly treatments could give way to pricier one-shot cures like Spark Therapeutics’ blindness drug. But insurers aren’t ready.
Date: April 06 , 2017
Questions for Discussions:
- Summarize the various pricing models presented in this report.
- What are the ethical and social considerations involved?
- How should the players decide on pricing in this industry?
- How should investors approach this discussion?